Financial News
Stories about Aimmune Therap
Uptrend Call Working As Aimmune Therapeu Stock Rises 27.6% (AIMT)
December 21, 2019
Benzinga's Top Upgrades, Downgrades For December 19, 2019
December 19, 2019
From Benzinga
Cramer Gives His Opinion On Synopsys, Cisco And More
December 12, 2019
From Benzinga
4 Healthcare Stocks With FDA Approvals on the Horizon
December 12, 2019
From Motley Fool
The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win
December 12, 2019
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
December 11, 2019
From Benzinga
The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint
December 11, 2019
From Benzinga
Notable Tuesday Option Activity: IIPR, LPI, AIMT
December 10, 2019
Tags
Stocks
From Market News Video
Stocks That Hit 52-Week Highs On Tuesday
December 10, 2019
From Benzinga
The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares
December 10, 2019
From Benzinga
Stocks That Hit 52-Week Highs On Friday
December 06, 2019
From Benzinga
February 2020 Options Now Available For Aimmune Therapeutics (AIMT)
December 03, 2019
Tags
Stocks
From Market News Video
Notable Monday Option Activity: RRD, NPTN, AIMT
December 02, 2019
Tags
Stocks
From Market News Video
First Week of AIMT January 2020 Options Trading
November 19, 2019
Tags
Stocks
From Market News Video
Noteworthy Wednesday Option Activity: IBM, HON, AIMT
November 13, 2019
Tags
Stocks
From Market News Video
20 Stocks That Could Double Your Money in 2020
November 11, 2019
From Motley Fool
Aimmune Therapeutics Inc (AIMT) Q3 2019 Earnings Call Transcript
November 06, 2019
From Motley Fool
The Daily Biotech Pulse: Sesen Rallies On Positive FDA Meeting, Supernus Flunks Late-Stage ADHD Trial, GW Pharma Earnings
November 06, 2019
From Benzinga
Aimmune CFO On Peanut Allergy Candidate Palforzia: 'There Is A Serious Unmet Need'
November 05, 2019
From Benzinga
17.8% Return Seen to Date on SmarTrend Aimmune Therapeu Call (AIMT)
November 05, 2019
The Week Ahead In Biotech: Smid-Cap Earnings Deluge, SITC Conference In The Spotlight
November 03, 2019
From Benzinga
Najarian Brothers Highlight Unusual Options Activity In Activision Blizzard, Cronos Group
October 24, 2019
From Benzinga
Stock Upgrades: Aimmune Therapeutics Shows Rising Relative Strength
October 11, 2019
Stocks Generating Improved Relative Strength: Aimmune Therapeutics
October 10, 2019
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.